Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net earnings/(loss)	$ (253)	$ (4,921)
Adjustments to reconcile net loss to net cash provided by/(used in) operating activities:
Depreciation and amortization	205	234
Impairments and (gain)/loss on disposal of assets, net	9	1
Share-based compensation	(28)	(20)
Provision for bad debts	16	29
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
(Increase)/decrease in trade receivables	(388)	229
(Increase)/decrease in inventories	(245)	356
Increase/(decrease) in accounts payable	313	(1,812)
Other accrued liabilities and operating items, net	585	5,211
Net cash provided by/(used in) operating activities	270	(653)
Cash flows from investing activities:
Additions to property and equipment	(78)	(72)
Purchase of investments	(17)	(3)
Proceeds from investments	1	2
Net cash used in investing activities	(94)	(73)
Cash flows from financing activities:
Net change in short-term borrowings	0	(2)
Reduction of long-term obligations	(40)	(74)
Net tax withholdings from share-based compensation	(12)	(13)
Dividends on common shares	(146)	(146)
Purchase of treasury shares	0	(350)
Net cash used in financing activities	(198)	(585)
Effect of exchange rate changes on cash and equivalents	(3)	(8)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(25)	(1,319)
Cash and equivalents at beginning of period	2,771	2,531
Cash and equivalents at end of period	$ 2,746	$ 1,212